NCT06307795View on ClinicalTrials.gov

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 24, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

October 31, 2027

Conditions
Locally Advanced or Metastatic Solid Tumors
Interventions
DRUG

ANS014004

Varying doses of ANS014004

Trial Locations (8)

10003

RECRUITING

Resarch Site, New York

22031

RECRUITING

NEXT Oncology, Virginia, Fairfax

32804

RECRUITING

Advent Health, Orlando

48202

RECRUITING

Research Site, Detroit

77030

RECRUITING

The University of Texas - MD Anderson Cancer Center, Houston

80218

RECRUITING

Sarah Cannon Research Institute, Denver

92093

RECRUITING

Research Site, San Diego

98195

RECRUITING

Research Site, Seattle

All Listed Sponsors
lead

Avistone Biotechnology Co., Ltd.

INDUSTRY